İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Biological evaluation of Schiff bases containing dopamine as antibacterial /antifungal and potential Anti COVID-19 agents: Design, synthesis, characterization, molecular docking studies, and ADME properties

ISSN0022-2860
YÖKSİS OpenAlex
Yıl2023
Atıf20OpenAlex
Yüzdelik%88,4
FWCI2,291,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJournal of Molecular Structure
  • Katalog eşleşmesi (ISSN)Journal of Molecular Structure
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

20atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 15 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activityAtıf 5 · OpenAlex
  2. 2025 Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activityAtıf 5 · OpenAlex
  3. 2025 Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activityAtıf 5 · OpenAlex
  4. 2025 Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activityAtıf 5 · OpenAlex
  5. 2025 Synthesis of new sulfa drugs containing FDA-approved sulfa pyridine: Evaluation of cholinesterase inhibition, antimicrobial, antibiofilm, anticancer, and antioxidant activities, along with theoretical calculation and molecular docking studyAtıf 4 · OpenAlex
  6. 2025 Synthesis of new sulfa drugs containing FDA-approved sulfa pyridine: Evaluation of cholinesterase inhibition, antimicrobial, antibiofilm, anticancer, and antioxidant activities, along with theoretical calculation and molecular docking studyAtıf 4 · OpenAlex
  7. 2025 Synthesis of new sulfa drugs containing FDA-approved sulfa pyridine: Evaluation of cholinesterase inhibition, antimicrobial, antibiofilm, anticancer, and antioxidant activities, along with theoretical calculation and molecular docking studyAtıf 4 · OpenAlex
  8. 2024 Sulfonyl hydrazone derivatives containing acetonaphtone as anticholinesterase inhibitors for the treatment of Alzheimers: X-ray single-crystal analysis, and multifaced theoretical calculationsAtıf 2 · OpenAlex
  9. 2024 Sulfonyl hydrazone derivatives containing acetonaphtone as anticholinesterase inhibitors for the treatment of Alzheimers: X-ray single-crystal analysis, and multifaced theoretical calculationsAtıf 2 · OpenAlex
  10. 2024 Sulfonyl hydrazone derivatives containing acetonaphtone as anticholinesterase inhibitors for the treatment of Alzheimers: X-ray single-crystal analysis, and multifaced theoretical calculationsAtıf 2 · OpenAlex

Yazarlar

6
  1. Ayşe ÜNLÜ 1
  2. ÜMMÜHAN ÖZDEMİR ÖZMEN 2
  3. SALİHA ALYAR ÇANKIRI KARATEKİN ÜNİVERSİTESİ 3
  4. Ali Öztürk 4
  5. HAMİT ALYAR 5
  6. AYLA BALABAN GÜNDÜZALP 6